SIRT1 gene is associated with major depressive disorder in the Japanese population

Journal of Affective Disorders

Volumn 126, Issue 1-2, 2010, Pages 167-173

  Kishi, Taro ^a   Yoshimura, Reiji ^b   Kitajima, Tsuyoshi ^a   Okochi, Tomo ^a   Okumura, Takenori ^a   Tsunoka, Tomoko ^a   Yamanouchi, Yoshio ^a   Kinoshita, Yoko ^a   Kawashima, Kunihiro ^a   Fukuo, Yasuhisa ^a   Naitoh, Hiroshi ^a   Umene Nakano, Wakako ^b   Inada, Toshiya ^c   Nakamura, Jun ^b   Ozaki, Norio ^d   Iwata, Nakao ^a  

^a FUJITA HEALTH UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b UNIVERSITY OF OCCUPATIONAL AND ENVIRONMENTAL HEALTH   (Japan)

^c SEIWA HOSPITAL   (Japan)

^d NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Linkage disequilibrium; Major depressive disorder; SIRT1 gene; SSRI response; Tagging SNP

Indexed keywords

BENZODIAZEPINE; FLUVOXAMINE; PAROXETINE; SERTRALINE;

ADULT; ALLELE; ANXIETY DISORDER; ARTICLE; CASE CONTROL STUDY; DRUG DOSE INCREASE; DRUG RESPONSE; FEMALE; GENE; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENOTYPE; HAPLOTYPE; HUMAN; JAPANESE; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE; PRIORITY JOURNAL; RATING SCALE; REMISSION; SINGLE NUCLEOTIDE POLYMORPHISM; SIRT1 GENE; STRUCTURED INTERVIEW; STRUCTURED INTERVIEW GUIDE FOR HAMILTON RATING SCALE FOR DEPRESSION; TREATMENT RESPONSE;

ALLELES; DEPRESSIVE DISORDER, MAJOR; FEMALE; GENETIC ASSOCIATION STUDIES; GENOTYPE; HAPLOTYPES; HUMANS; JAPAN; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; PSYCHIATRIC STATUS RATING SCALES; SEROTONIN UPTAKE INHIBITORS; SIRTUIN 1; TREATMENT OUTCOME;

EID: 77956268388     PISSN: 01650327     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jad.2010.04.003     Document Type: Article

References (40)

1. G. Asher, D. Gatfield, M. Stratmann, H. Reinke, C. Dibner, F. Kreppel, R. Mostoslavsky, F.W. Alt, and U. Schibler SIRT1 regulates circadian clock gene expression through PER2 deacetylation Cell 134 2008 317 328
2. B. Barbini, F. Benedetti, C. Colombo, E. Guglielmo, E. Campori, and E. Smeraldi Perceived mood and skin body temperature rhythm in depression European Archives of Psychiatry and Clinical Neuroscience 248 1998 157 160
3. J.C. Barrett, B. Fry, J. Maller, and M.J. Daly Haploview: analysis and visualization of LD and haplotype maps Bioinformatics 21 2005 263 265 Oxford, England
4. W.J. Belden, and J.C. Dunlap SIRT1 is a circadian deacetylase for core clock components Cell 134 2008 212 214
5. C.L. Bowden Strategies to reduce misdiagnosis of bipolar depression Psychiatric Services 52 2001 51 55 Washington, D.C
6. H.J. Cho, H. Lavretsky, R. Olmstead, M.J. Levin, M.N. Oxman, and M.R. Irwin Sleep disturbance and depression recurrence in community-dwelling older adults: a prospective study American Journal of Psychiatry 165 2008 1543 1550
7. F. Dudbridge Pedigree disequilibrium tests for multilocus haplotypes Genetic Epidemiology 25 2003 115 121
8. S.C. Gough, and M.C. O'Donovan Clustering of metabolic comorbidity in schizophrenia: a genetic contribution? Journal of Psychopharmacology 19 2005 47 55 Oxford, England
9. K.N. Green, J.S. Steffan, H. Martinez-Coria, X. Sun, S.S. Schreiber, L.M. Thompson, and F.M. LaFerla Nicotinamide restores cognition in Alzheimer's disease transgenic mice via a mechanism involving sirtuin inhibition and selective reduction of Thr231-phosphotau Journal of Neuroscience 28 2008 11,500 11,510
10. P.L. Haynes, J.R. McQuaid, S. Ancoli-Israel, and J.L. Martin Disrupting life events and the sleep-wake cycle in depression Psychological Medicine 36 2006 1363 1373
11. T. Kato Molecular genetics of bipolar disorder and depression Psychiatry and Clinical Neurosciences 61 2007 3 19
12. T. Kishi, T. Kitajima, M. Ikeda, Y. Yamanouchi, Y. Kinoshita, K. Kawashima, T. Okochi, N. Ozaki, and N. Iwata Association analysis of nuclear receptor Rev-erb alpha gene (NR1D1) with mood disorders in the Japanese population Neuroscience Research 62 2008 211 215
13. T. Kishi, T. Kitajima, M. Ikeda, Y. Yamanouchi, Y. Kinoshita, K. Kawashima, T. Okochi, T. Okumura, T. Tsunoka, T. Inada, N. Ozaki, and N. Iwata Association study of clock gene (CLOCK) and schizophrenia and mood disorders in the Japanese population European Archives of Psychiatry and Clinical Neuroscience 259 2009 293 297
14. T. Kishi, T. Kitajima, M. Ikeda, Y. Yamanouchi, Y. Kinoshita, K. Kawashima, T. Okochi, T. Okumura, T. Tsunoka, N. Ozaki, and N. Iwata CLOCK may predict the response to fluvoxamine treatment in Japanese major depressive disorder patients Neuromolecular Medicine 11 2009 53 57
15. T. Kishi, T. Kitajima, M. Ikeda, Y. Yamanouchi, Y. Kinoshita, K. Kawashima, T. Okochi, N. Ozaki, and N. Iwata Orphan nuclear receptor Rev-erb alpha Gene (NR1D1) and fluvoxamine response in major depressive disorder in the Japanese population Neuropsychobiology 59 2009 234 238
16. T. Kishi, T. Kitajima, T. Tsunoka, M. Ikeda, Y. Yamanouchi, Y. Kinoshita, K. Kawashima, T. Okochi, T. Okumura, T. Inada, N. Ozaki, and N. Iwata Genetic association analysis of serotonin 2A receptor gene (HTR2A) with bipolar disorder and major depressive disorder in the Japanese population Neuroscience Research 64 2009 231 234
17. T. Kishi, T. Kitajima, T. Tsunoka, T. Okumura, M. Ikeda, T. Okochi, Y. Kinoshita, K. Kawashima, Y. Yamanouchi, N. Ozaki, and N. Iwata Possible association of prokineticin 2 receptor gene (PROKR2) with mood disorders in the Japanese population Neuromolecular Medicine 11 2009 114 122
18. Kishi, T., Yoshimura, R., Kitajima, T., Okochi, T., Okumura, T., Tsunoka, T., Yamanouchi, Y., Kinoshita, Y., Kawashima, K., Naitoh, H., Nakamura, J., Ozaki, N., Iwata, N., in press. HTR2A is associated with SSRI response in major depressive disorder in a Japanese cohort. Neuromolecular Medicine.
19. J.Y. Lee, K. Ahn, B.G. Jang, S.H. Park, H.J. Kang, J.I. Heo, Y.J. Ko, M.H. Won, K. Tae-Cheon, S.A. Jo, and M.J. Kim Nicotinamide reduces dopamine in postnatal hypothalamus and causes dopamine-deficient phenotype Neuroscience Letters 461 2009 163 166
20. D. Liu, R. Gharavi, M. Pitta, M. Gleichmann, and M.P. Mattson Nicotinamide prevents NAD+ depletion and protects neurons against excitotoxicity and cerebral ischemia: NAD+ consumption by SIRT1 may endanger energetically compromised neurons Neuromolecular Medicine 11 2009 28 42
21. H.A. Mansour, J. Wood, T. Logue, K.V. Chowdari, M. Dayal, D.J. Kupfer, T.H. Monk, B. Devlin, and V.L. Nimgaonkar Association study of eight circadian genes with bipolar I disorder, schizoaffective disorder and schizophrenia Genes, Brain, and Behavior 5 2006 150 157
22. C.A. McClung Circadian genes, rhythms and the biology of mood disorders Pharmacology and Therapeutics 114 2007 222 232
23. C.A. McClung Clock genes and bipolar disorder: implications for therapy Pharmacogenomics 8 2007 1097 1100
24. C.A. McClung Role for the Clock gene in bipolar disorder Cold Spring Harbor Symposia on Quantitative Biology 72 2007 637 644
25. Y. Nakahata, M. Kaluzova, B. Grimaldi, S. Sahar, J. Hirayama, D. Chen, L.P. Guarente, and P. Sassone-Corsi The NAD+-dependent deacetylase SIRT1 modulates CLOCK-mediated chromatin remodeling and circadian control Cell 134 2008 329 340
26. Y. Nakahata, S. Sahar, G. Astarita, M. Kaluzova, and P. Sassone-Corsi Circadian control of the NAD+ salvage pathway by CLOCK-SIRT1 Science 324 2009 654 657 New York, N.Y
27. C.M. Nievergelt, D.F. Kripke, T.B. Barrett, E. Burg, R.A. Remick, A.D. Sadovnick, S.L. McElroy, P.E. Keck Jr., N.J. Schork, and J.R. Kelsoe Suggestive evidence for association of the circadian genes PERIOD3 and ARNTL with bipolar disorder American Journal of Medical Genetics Part B Neuropsychiatr Genetics 141B 2006 234 241
28. R. Peveler, and T. Kendrick Selective serotonin reuptake inhibitors: THREAD trial may show way forward BMJ Clinical Research 330 2005 420 421
29. S. Purcell, S.S. Cherny, and P.C. Sham Genetic power calculator: design of linkage and association genetic mapping studies of complex traits Bioinformatics 19 2003 149 150 Oxford, England
30. K.M. Ramsey, J. Yoshino, C.S. Brace, D. Abrassart, Y. Kobayashi, B. Marcheva, H.K. Hong, J.L. Chong, E.D. Buhr, C. Lee, J.S. Takahashi, S. Imai, and J. Bass Circadian clock feedback cycle through NAMPT-mediated NAD+ biosynthesis Science 324 2009 651 654 New York, N.Y
31. D. Riemann, F. Hohagen, M. Bahro, and M. Berger Sleep in depression: the influence of age, gender and diagnostic subtype on baseline sleep and the cholinergic REM induction test with RS 86 European Archives of Psychiatry and Clinical Neuroscience 243 1994 279 290
32. S. Saito, N. Takahashi, R. Ishihara, M. Ikeda, T. Suzuki, T. Kitajima, Y. Yamanouchi, N. Iwata, M. Yamada, K. Yoshida, T. Inada, and N. Ozaki Association study between vesicle-associated membrane protein 2 gene polymorphisms and fluvoxamine response in Japanese major depressive patients Neuropsychobiology 54 2006 226 230
33. J.A. Samson, S.M. Mirin, M. Griffin, D. Borrelli, and J.J. Schildkraut Urinary MHPG and clinical symptoms in patients with unipolar depression Psychiatry Research 51 1994 157 165
34. E.M. Scott, A.M. Carter, and P.J. Grant Association between polymorphisms in the Clock gene, obesity and the metabolic syndrome in man International Journal of Obesity 32 2008 658 662 2005
35. E.M. Scott, A.M. Carter, and P.J. Grant Diabetes and cardiovascular disease: related disorders created by disturbances in the endogenous clock Journal of the Indian Medical Association 106 736-738 2008 740
36. S. Sookoian, C. Gemma, T.F. Gianotti, A. Burgueno, G. Castano, and C.J. Pirola Genetic variants of Clock transcription factor are associated with individual susceptibility to obesity American Journal of Clinical Nutrition 87 2008 1606 1615
37. J.S. Takahashi, H.K. Hong, C.H. Ko, and E.L. McDearmon The genetics of mammalian circadian order and disorder: implications for physiology and disease Nature Reviews 9 2008 764 775
38. H. Wijnen Circadian rhythms. A circadian loop asSIRTs itself Science 324 2009 598 599 New York, N.Y
39. J.B. Williams A structured interview guide for the Hamilton Depression Rating Scale Archives of General Psychiatry 45 1988 742 747
40. P.Y. Woon, P.J. Kaisaki, J. Braganca, M.T. Bihoreau, J.C. Levy, M. Farrall, and D. Gauguier Aryl hydrocarbon receptor nuclear translocator-like (BMAL1) is associated with susceptibility to hypertension and type 2 diabetes Proceedings of the National Academy of Sciences of the United States of America 104 2007 14,412 14,417